Contact us

Oral Liquids CDMO Companies
Oral Liquid Formulations Contract Manufacturing Services

Your Trusted Partners for Oral Liquid and Semisolid Formulations Contract Manufacturing and Development

Applied Filters:Oral liquids and semisolids×FDF / DRUG PRODUCTS×Clear All
Showing 39 facilities
Laboratorio REIG JOFRE, SA (TOLEDO PLANT)
Spain

Laboratorio REIG JOFRE, SA (TOLEDO PLANT)

LABORATORIO REIG JOFRE SA

Betalactam antibiotics (FDF) development and manufacturing state-of-the-art facilities.

Discover our facility

MARKETS: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), INVIMA (Colombia), SFDA (Saudi Arabia), TGA (Australia)

REGION: APAC, MENA, LATAM, Europe, North America

COMPLIANCE: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)

BATCH SIZE: Large, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (J) Antiinfectives for systemic use

CONTROLLED SUBSTANCES: Lowest potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)
Spain

Laboratorio REIG JOFRE, SA (BARCELONA PLANT)

LABORATORIO REIG JOFRE SA

Injectable (lyo and liquid) and Liquid manufacturing facilities.

Discover our facility

BSL (Biological Safety Level): 3, 1, 2

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)

REGION: Europe

BATCH SIZE: Large, Medium

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

COMPLIANCE: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

ALPHAVET Zrt.- Bábolna Manufacturing Plant
Hungary

ALPHAVET Zrt.- Bábolna Manufacturing Plant

Alphavet Zrt.

The plant is EU GMP certified and produces veterinary medicinal products for 18 EU Member States and 7 other European coutries outside the EU.

Discover our facility

MARKETS: EMA (EU)

REGION: Europe

COMPLIANCE: ISO, EMA (EU GMP)

BATCH SIZE: Large, Medium

CATEGORY / PRODUCT: NUTRACEUTICALS, FDF / DRUG PRODUCTS

USE: Veterinary

SERVICES: Manufacturing services, Analytical / QC services, Regulatory services, Packaging

Sidefarma
Portugal

Sidefarma

Sidefarma SA

CMO specialized in the manufacture of small and medium size batches for pharmaceutical companies across the world in regulated markets.

Discover our facility

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), Health Canada (Canada), DIGEMID (Peru), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, EDE (UAE), TGA (Australia)

REGION: Europe

COMPLIANCE: ISO, UAE Ministry of Health & Prevention, EMA (EU GMP)

USE: Human

SERVICES: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

BATCH SIZE: Small, Medium

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

FAES FARMA | DERIO facility
Spain

FAES FARMA | DERIO facility

FAES FARMA

Developer and manufacturer of human medicinal products.

Discover our facility

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), MFDS (South Korea), EDE (UAE), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), French Service-Public (CIR), NMPA (China GMP), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

OEB (Occupational Exposure Banding): 1 / low-hazard (PDE > 10,000 µg/day)

Aenova Group - Location Regensburg, Germany
Germany

Aenova Group - Location Regensburg, Germany

Aenova

Competence Center high potent solids (oncology) conventional solids - specialty semisolids & liquids.

Discover our facility

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, NUTRACEUTICALS, FDF / DRUG PRODUCTS, PARTICLE ENGINEERING

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

Aenova Group - Location Feldkirchen, Germany
Germany

Aenova Group - Location Feldkirchen, Germany

Aenova

Competence Center Semisolids and Liquids.

Discover our facility

MARKETS: EMA (EU), FDA (USA), Russian Health Authorities

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, Roszdravnadzor (Russia GMP), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, FDF / DRUG PRODUCTS

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Aenova Group - Location Bad Aibling, Germany
Germany

Aenova Group - Location Bad Aibling, Germany

Aenova

Competence Center Blister packaging Third party packaging High volume plant for effervescents.

Discover our facility

MARKETS: EMA (EU), FDA (USA)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, IFS, EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, NUTRACEUTICALS, FDF / DRUG PRODUCTS

USE: Human, Veterinary

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Aenova Group - Location Carugate, Italy
Italy

Aenova Group - Location Carugate, Italy

Aenova

Competence Center Semisolids and non-sterile liquids.

Discover our facility

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)

REGION: Europe

COMPLIANCE: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, FDF / DRUG PRODUCTS

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

Adragos Pharma | Leipzig
Germany

Adragos Pharma | Leipzig

Adragos Pharma

Non-sterile semi-solid and liquid pharmaceutical products.

Discover our facility

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea)

SERVICES: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: EMA (EU GMP)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Adragos Pharma | Athens
Greece

Adragos Pharma | Athens

Adragos Pharma

Specializes in the development of Value Added Medicines and has been recently upgraded with HPAPI capabilities.

Discover our facility

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF

BATCH SIZE: Large, Small, Medium

USE: Human

CATEGORY / PRODUCT: SERVICES, FDF / DRUG PRODUCTS

Seda Pharma Development Services
United Kingdom

Seda Pharma Development Services

Seda Pharma Development Services Ltd

Seda Pharmaceutical Development Services specialises in integrated Pharmaceutical Development and Clinical Pharmacology.

Discover our facility

THERAPEUTIC AREAS OF EXPERTISE (ATC): (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (D) Dermatologicals, (M) Musculoskeletal system, (N) Nervous system, (B) Blood and blood forming organs

MARKETS: TGA (Australia), Rest of World, EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India)

BATCH SIZE: Small, Medium

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

COMPLIANCE: MHRA (UK GMP), ECOVADIS

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

REGION: Europe

USE: Human

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+22 more facilities

Create free account

Oral liquid and semi-solid forms, including syrups, suspensions, solutions, emulsions, gels, and pastes, are essential in drug delivery for ease of administration and precise dosing. These forms are particularly beneficial for pediatric, geriatric, and dysphagic patients. Oral Liquids Contract Development and Manufacturing Organizations (CDMOs) support pharmaceutical companies with tailored solutions for formulation, development, and large-scale production while ensuring high safety, quality, and regulatory compliance.

How to Choose an Oral Liquids Contract Manufacturer

Choosing the right oral liquids contract manufacturer is critical for product stability, taste-masking, and meeting strict regulatory standards. Manufacturers should have proven experience in producing various formulations, from syrups and suspensions to gels and emulsions, while addressing specific therapeutic and market needs.

It is essential to assess the manufacturer’s expertise in solubility enhancement, viscosity optimization, and flavoring technologies, as well as their compliance with global standards such as EMA, FDA, and WHO. Scalability is also important to ensure smooth transitions from clinical trial batches to high-volume commercial production.

Key Services Offered by Oral Liquids CDMOs

Formulation Development: Expertise in creating stable, effective, and palatable formulations, including taste-masking for oral liquids and texture optimization for semi-solids.

Manufacturing: High-capacity production for syrups, solutions, suspensions, emulsions, gels, and pastes using advanced technology to ensure consistency and precision.

Regulatory Support: Comprehensive assistance with regulatory filings and compliance for global markets, facilitating approvals for both oral liquid and semi-solid forms.

Packaging Solutions: Customized packaging options such as bottles, sachets, unit-dose vials, and tubes designed to preserve stability and ensure accurate dosing.

Analytical Testing: Rigorous testing to ensure product stability, homogeneity, viscosity, and overall quality at all stages of development and production.

Advantages of Partnering with Oral Liquid Forms CDMOs

Regulatory Expertise: Oral liquids CDMOs have extensive experience in navigating complex global regulatory landscapes, ensuring compliance for market approval.

Advanced Facilities: Cutting-edge technologies and equipment for aseptic and non-aseptic processing ensure precision and high-quality production for all formulations.

Flexibility and Scalability: Oral liquids CDMOs offer production solutions that adapt to your evolving project needs, from clinical trial batches to full-scale commercial manufacturing.

Innovation and Customization: Expertise in solubility enhancement, flavor optimization, and viscosity adjustments ensures patient-friendly and effective products.

Cost Efficiency: Streamlined production processes help ensure cost-effective manufacturing without compromising quality or safety.

Oral Liquids CDMO Companies

Some of the top oral liquid forms CDMO companies:

  • Lannett: Oral Solid Dose (OSD) and Liquid Forms. [See CDMO profile]
  • FAES FARMA: Developer and manufacturer of human medicinal products. [See CDMO profile]
  • Reig Jofre: Injectable (lyo and liquid) and oral liquids manufacturing facilities. [See CDMO profile]
  • Pharmaloop (a Salvat company): Fully integrated CDMO solutions for non-sterile multi-dose liquids. [See CDMO profile]
  • ASCIL Biopharm: GMP facility fully equipped for R&D and pharmaceutical development. Includes laboratories and a pilot plant for technical and clinical batches of sterile products. [See CDMO profile]
  • Aenova Group: Competence center specializing in conventional solid dosage forms, clinical services, as well as semisolids and liquid formulations. [See CDMO profile]
  • Ascendia Pharmaceutical Solutions: GMP-certified CDMO delivering advanced sterile and non-sterile pharmaceutical manufacturing, formulation development, and comprehensive analytical testing services. [See CDMO profile]
  • Cambrex: CDMO focused on late-stage and commercial API development, offering cGMP-compliant manufacturing capabilities. [See CDMO profile]
  • Content Group: Tubilux Pharma site serving as registered office and pharmaceutical manufacturing facility. [See CDMO profile]
  • Darnytsia Kyiv: Integrated pharmaceutical manufacturer combining advanced facilities, rigorous quality systems, and expert teams to deliver compliant and innovative solutions. [See CDMO profile]
  • i+Med: Developer and manufacturer of innovative drug products utilizing controlled-release technologies. [See CDMO profile]
  • Seda Pharma Development Services: Specialist provider of integrated pharmaceutical development and clinical pharmacology services, supporting efficient development from conventional to complex formulations. [See CDMO profile]
  • Sidefarma: CDMO specialized in small- and medium-scale batch manufacturing for pharmaceutical companies, serving regulated markets under European quality standards. [See CDMO profile]

Related information

Let MAI CDMO Help You Find the Right Oral Liquid and Semi-Solid Manufacturing Partner

Finding the ideal oral liquids CDMO partner can be a complex task, but MAI CDMO is here to simplify the process. We connect you with trusted manufacturers specializing in both innovative and high-quality oral liquid and semi-solid formulations.

Our experienced team works closely with you to align your project goals with the strengths of leading oral liquids CDMOs, ensuring a smooth journey from development to market.

Contact us today to explore the best oral liquid forms contract manufacturers and take the next step in your pharmaceutical journey with a trusted partner.